Assessing the effects of bupropion SR on mood dimensions of depression.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Affective Disorders

• Publication date

  2004-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0165-0327(02)00306-3PMID 15013248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.

  2002cited by this paper
• Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?

  2001cited by this paper
• Can recovery from depression be achieved?

  2001influential reference
• Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

  2001cited by this paper
• Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal.

  1998cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

  1997cited by this paper
• SAS System for Mixed Models

  1996cited by this paper
• The behavioral neurochemistry of motivation: methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine.

  1996cited by this paper
• Testing a tripartite model: II. Exploring the symptom structure of anxiety and depression in student, adult, and patient samples.

  1995influential reference
• Bupropion: a review of its mechanism of antidepressant activity.

  1995cited by this paper
• Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales.

  1995cited by this paper
• Dopamine and the structure of personality: relation of agonist-induced dopamine activity to positive emotionality.

  1994cited by this paper
• Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic Mechanism

  1994cited by this paper
• Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

  1993cited by this paper
• Hierarchical Linear Models: Applications and Data Analysis Methods

  1992cited by this paper
• Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications.

  1991cited by this paper
• Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.

  1989cited by this paper
• Dopamine and depression: a review of recent evidence. I. Empirical studies.

  1983cited by this paper
• Dopamine and depression: a review of recent evidence. II. Theoretical approaches.

  1983cited by this paper
• Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments.

  1983cited by this paper
• Genes for tRNAIle and tRNAAla in the spacer between the 16S and 23S rRNA genes of a blue-green alga: strong homology to chloroplast tRNA genes and tRNA genes of the E. coli rrnD gene cluster

  1983cited by this paper
• Neuroleptics and operant behavior: The anhedonia hypothesis

  1982cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Treatment response to bupropion: an investigation of changes in resting-state functional connectivity in patients with major depressive disorder.

  2025cites this paper
• Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.

  2025cites this paper
• Efficacy and Tolerability of Bupropion in Major Depressive Disorder with Comorbid Anxiety Symptoms: A Systematic Review

  2025cites this paper
• Recent Change in Anhedonia, Major Depression and Low-Grade Inflammation: Dangerous Liaisons? A Study Based on a Cohort Referred for Polysomnography

  2025cites this paper
• Reward Motives are Differentially Related to Depression, Anxiety, and ADHD Symptoms in Middle Childhood.

  2025cites this paper
• Combination therapy with citalopram, bupropion, and lithium for the amelioration of the depressive-related effects induced by dexamethasone in male mice.

  2025cites this paper
• Anhedonia: Current and future treatments

  2025cites this paper
• From anxiety to depression: A longitudinal investigation into the role of anhedonia.

  2025cites this paper
• Coadministration of scopolamine and mGlu2 receptor negative allosteric modulator VU6001966 as a potential therapeutic approach for depression: Rat frontal cortex neurochemistry and behavior.

  2025cites this paper
• Addressing anhedonia in depression with antidepressant therapies

  2025cites this paper
• The Use of Ketamine for the Treatment of Anhedonia in Depression

  2024cites this paper
• Increased Inflammation and Treatment of Depression: From Resistance to Reuse, Repurposing, and Redesign.

  2023cites this paper
• Neuroticism mediates the association between childhood abuse and the well-being of community dwelling adult volunteers

  2023cites this paper
• Anhedonia and Depressive Disorders

  2023cites this paper
• Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies.

  2022cites this paper
• Pharmacological Treatments for Anhedonia.

  2022cites this paper
• Different depression: motivational anhedonia governs antidepressant efficacy in Huntington’s disease

  2022cites this paper
• Emotion Context Insensitivity is generalized in individuals with major depressive disorder but not in those with subclinical depression.

  2022cites this paper
• Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression.

  2021cites this paper
• The effect of physical activity on anhedonia in individuals with depressive symptoms.

  2021cites this paper
• Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications

  2021cites this paper
• Towards Modeling Anhedonia and Its Treatment in Zebrafish

  2021cites this paper
• Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia

  2021cites this paper
• Characterizing anhedonia: A systematic review of neuroimaging across the subtypes of reward processing deficits in depression

  2020cites this paper
• Neurobiological predictors for clinical trajectories in fully remitted depressed patients

  2020cites this paper
• Gaming Disorder and Its Treatment

  2020cites this paper
• Appetitive Needs and Addiction

  2020cites this paper
• Anhedonia in Addictive Behaviors

  2020cites this paper
• Feedback Models for Gambling Control: The Use and Efficacy of Online Responsible Gambling Tools

  2020cites this paper
• Multiple Memory Systems, Addiction, and Health Habits: New Routes for Translational Science

  2020cites this paper
• Substance and Behavioral Addictions Assessment Instruments

  2020cites this paper
• Prevention and Treatment of “Food Addiction”

  2020cites this paper
• Prevention and Treatment of Work Addiction

  2020cites this paper
• Neurobiological Foundations of Behavioral Addictions

  2020cites this paper
• American Legal Issues in Addiction Treatment and Research

  2020cites this paper
• Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction

  2020cites this paper
• Tanning as an Addiction: The State of the Research and Implications for Intervention

  2020cites this paper
• Qualitative Approaches to the Study of Substance and Behavioral Addictions

  2020cites this paper
• Philosophical Issues in the Addictions

  2020cites this paper
• Food versus Eating Addictions

  2020cites this paper
• Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.

  2020cites this paper
• Irritability as a Transdiagnostic Vulnerability Trait:Current Issues and Future Directions.

  2020cites this paper
• Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables

  2020cites this paper
• Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report.

  2020cites this paper
• The Physical and Social Environments as Determinants of Health: Implications for Substance and Behavioral Addictions

  2020cites this paper
• Adolescent Drug Misuse Prevention: Challenges in School-Based Programming

  2020cites this paper
• Passionate Love Addiction: An Evolutionary Survival Mechanism That Can Go Terribly Wrong

  2020cites this paper
• The Prevention and Treatment of Gambling Disorders: Some Art, Some Science

  2020cites this paper
• Novel Psychoactive Substances: A New Challenge for Prevention and Treatment

  2020cites this paper
• Human Laboratory Paradigms in Addictions Research

  2020cites this paper
• Human Neurobiological Approaches to Hedonically Motivated Behaviors

  2020cites this paper
• The Role of Culture in Addiction

  2020cites this paper
• Prevention and Treatment of Compulsive Buying Disorder

  2020cites this paper
• Treatment of Alcohol, Tobacco, and Other Drug (ATOD) Misuse

  2020cites this paper
• Measurement, Prevention, and Treatment of Exercise Addiction

  2020cites this paper
• Sensitization of Incentive Salience and the Transition to Addiction

  2020cites this paper
• Precision Behavioral Management (PBM): A Novel Genetically Guided Therapy to Combat Reward Deficiency Syndrome (RDS) Relevant to the Opiate Crisis

  2020cites this paper
• Behavioral Economics and Addictive Disorders

  2020cites this paper
• Prevention and Treatment of Sex Addiction

  2020cites this paper
• Neurobiology of Substance Addictions

  2020cites this paper
• Foreword: What are the Boundaries of Addictions?

  2020cites this paper
• Behavioral Economic Considerations of Novel Addictions and Nonaddictive Behavior: Research and Analytic Methods

  2020cites this paper
• Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review

  2019cites this paper
• Anhedonia in Depression: Mechanisms, Assessment, and Therapeutics

  2019cites this paper
• Changes in Positive and Negative Affect During Pharmacological Treatment and Cognitive Therapy for Major Depressive Disorder: A Secondary Analysis of Two Randomized Controlled Trials

  2019cites this paper
• Personality in a Hierarchical Model of Psychopathology

  2018cites this paper
• Behaviour and Neural Indices of the Abuse Liability associated with Intraoral Self-administration of High Fructose Corn Syrup

  2018cites this paper
• L’anhédonie dans la dépression unipolaire : de son évaluation à sa prise en charge

  2018cites this paper
• Comparative Effectiveness of Antidepressant Medication versus Psychological Intervention on Depression Symptoms in Women with Infertility and Sexual Dysfunction

  2018cites this paper
• Anhedonia w zaburzeniach depresyjnych

  2017cites this paper
• Hypothalamic‐pituitary‐adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one‐week randomized Phase 1b trial

  2017cites this paper
• CNS Target Identification and Validation: Avoiding the Valley of Death or Naive Optimism?

  2017cites this paper
• Dissociable temporal effects of bupropion on behavioural measures of emotional and reward processing in depression

  2017cites this paper
• Addressing Neuroticism in Psychological Treatment

  2017cites this paper
• Anticipatory and Hedonic Reward Response in Major Depression: Underlying Molecular Correlates and Relationship with Treatment Outcome

  2017cites this paper
• A test of the tripartite model of anxiety and depression in postpartum psychiatric inpatients

  2016cites this paper
• Affect at the different phases of cognitive behavioral therapy : An evaluation of psychotherapy provided by candidates

  2016cites this paper
• The structure of negative emotional states in a postpartum inpatient sample.

  2016cites this paper
• Pharmacological and Non-pharmacological Therapeutic Strategies for Improvement of State-Trait Anxiety: A Randomized Controlled Trial Among Iranian Infertile Women With Sexual Dysfunctions

  2016cites this paper
• Mood and metabolism: Anhedonia as a clinical target in Type 2 diabetes.

  2016cites this paper
• Manipulating dopaminergic activity with bupropion : effects on reward and emotional processing biases implicated in depression

  2016cites this paper
• Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant

  2016influential citation
• Eating and Appetite

  2015cites this paper
• Antidepressant drug development: Focus on triple monoamine reuptake inhibition

  2015influential citation
• Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication

  2015cites this paper
• Risk factors for incident depression in patients at first acute coronary syndrome.

  2015cites this paper
• Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients.

  2014cites this paper
• Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?

  2014cites this paper
• The Nature, Diagnosis, and Treatment of Neuroticism

  2014cites this paper
• A preliminary investigation of the effects of the unified protocol on temperament.

  2014cites this paper
• Restoration of positive mood states in major depression as a potential drug development target

  2014cites this paper
• Anhedonia revisited: Is there a role for dopamine-targeting drugs for depression?

  2013cites this paper
• [Anhedonia in depression].

  2013cites this paper
• [Anhedonia in depression].

  2013cites this paper
• Antidepressant Effects on Emotional Temperament: Toward a Biobehavioral Research Paradigm for Major Depressive Disorder

  2012cites this paper
• Persistence on a Stress-challenge Task Before Initiating Buprenorphine Treatment Was Associated With Successful Transition From Opioid Use to Early Abstinence

  2012cites this paper
• Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development

  2012cites this paper
• Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

  2012cites this paper
• Parsing anhedonia: Effort-based decision-making as a translational model of motivational deficits in Major Depressive Disorder

  2012cites this paper
• Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits.

  2011cites this paper